NeoImmuneTech Inc is a biotechnology company based in Rockville, MD that is dedicated to expanding the horizon of immuno-oncology and enhancing immunity to infectious diseases through their innovative research and development. With a focus on T cell amplification, their lead drug candidate, NT-I7, offers a unique approach to boosting the immune system.
Driven by a team of key members and scientific advisors, NeoImmuneTech is advancing clinical development in the fields of oncology and immunology, with a strong pipeline of drug candidates such as NT2020, NT3020, NT4010, and NT5010. Committed to scientific collaboration and innovation, the company aims to make significant contributions to the field of immuno-oncology and improve patient outcomes.
Generated from the website